Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centella asiatica ointment versus silver sulfadiazine for third-degree burn wounds
IRCT20131006014915N2Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of centella asiatica and silver sulfadiazine in full-thickness burn (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Time to re-epithelialization and Time to complete healing. Started Jun 2018; status: completed.
02
Drugs
centella asiaticasilver sulfadiazine
03
Conditions
full-thickness burn
Beyond the preview
Go deeper on IRCT20131006014915N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131006014915N2.